Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotechnology Innovation Organization
Pharma
Ono-Deciphera, Novartis-PeptiDream, WuXi Bio—Fierce Pharma Asia
Ono will buy Deciphera for $2.4 billion. Novartis invests further in radiotherapy with two deals. WuXi Biologics has withdrawn from the BIO 2024.
Angus Liu
May 3, 2024 7:20am
WuXi Bio pulls out of 2024 BIO convention
May 1, 2024 2:48pm
BIO survey to elucidate US biopharma's reliance on Chinese CDMOs
May 1, 2024 11:00am
Takeda joins growing list of drugmakers to leave trade group BIO
Apr 26, 2024 7:25am
Novartis reviews ties to China amid US biosecurity crackdown
Apr 23, 2024 11:07am
BIO's top lobbyist heads out the door
Apr 10, 2024 3:22pm